[A follow-up study on cases treated with daily and intermittent regimens of rifampicin (author's transl)].
D006801:Humans; D012293:Rifampin / Q000008:administration & dosage*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000627:therapeutic use
D012293:Rifampin